iRadimed Sees Q4 GAAP EPS $0.53-$0.57 vs $0.58 Est

Benzinga · 1d ago
iRadimed (NASDAQ:IRMD) is looking for Q4 GAAP EPS of $0.53-$0.57 vs $0.58 analyst estimate..